Antin Infrastructure Partners S.A. Share Price
Equities
ANTIN
FR0014005AL0
Investment Management & Fund Operators
|
Market Closed -
Other stock markets
|
After hours 20:59:59 | |||
| 11.00 EUR | -0.90% |
|
11.02 | +0.18% |
| 01-08 | Antin Enters Clinical Trials Market with Acquisition of Emsere |  |
| 01-08 | Antin to buy clinical trial rental company Emsere | RE |
| Capitalization | 1.97B 2.29B 1.83B 1.7B 3.18B 207B 3.43B 21.04B 8.28B 98.92B 8.59B 8.41B 362B | P/E ratio 2025 * |
17.6x | P/E ratio 2026 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise value | 1.68B 1.96B 1.57B 1.46B 2.72B 177B 2.93B 18.01B 7.09B 84.69B 7.35B 7.2B 310B | EV / Sales 2025 * |
5.66x | EV / Sales 2026 * | 5.3x |
| Free-Float |
32.77% | Yield 2025 * |
6.36% | Yield 2026 * | 6.33% |
Last Transcript: Antin Infrastructure Partners S.A.
| 1 day | -0.90% | ||
| 1 week | -1.43% | ||
| Current month | -2.65% | ||
| 1 month | +9.13% | ||
| 3 months | -2.31% | ||
| 6 months | -4.84% | ||
| Current year | -2.65% |
| 1 week | 10.94 |  | 11.64 |
| 1 month | 10.08 | | 11.64 |
| Current year | 10.94 | | 11.64 |
| 1 year | 9.35 | | 13.06 |
| 3 years | 9.35 | | 23.3 |
| 5 years | 9.35 | | 35.92 |
| 10 years | 9.35 | | 35.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alain Rauscher
CEO | Chief Executive Officer | 67 | 17/06/2021 |
Mélanie Biessy
DFI | Director of Finance/CFO | 54 | 10/07/2025 |
Kaisa Valtanen
CIO | Chief Investment Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Alain Rauscher
CHM | Chairman | 67 | 17/06/2021 |
Mark Crosbie
BRD | Director/Board Member | 66 | 17/06/2021 |
Mélanie Biessy
BRD | Director/Board Member | 54 | 17/06/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -1.43% | +3.58% | -50.76% | 2.31B | |
| +2.23% | -2.42% | -4.26% | +86.63% | 122B | |
| +1.54% | -2.75% | -6.49% | +144.59% | 116B | |
| +0.42% | -3.45% | -3.17% | +119.34% | 37.28B | |
| +0.11% | -0.14% | +29.72% | +95.53% | 23.6B | |
| +0.14% | +2.08% | +20.41% | +22.31% | 17.39B | |
| +1.95% | +1.41% | -5.52% | +10.48% | 14.66B | |
| +1.38% | +2.03% | +34.97% | -14.77% | 13.18B | |
| +2.75% | -2.59% | +33.22% | +137.30% | 11.79B | |
| +1.96% | -2.74% | -30.23% | +26.01% | 10.17B | |
| Average | +1.09% | -2.12% | +7.22% | +57.67% | 36.79B | |
| Weighted average by Cap. | +1.52% | -3.45% | +0.38% | +98.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 297M 346M 277M 257M 480M 31.26B 518M 3.18B 1.25B 14.95B 1.3B 1.27B 54.8B | 324M 377M 301M 280M 523M 34.04B 564M 3.46B 1.36B 16.28B 1.41B 1.38B 59.66B |
| Net income | 113M 131M 105M 97.58M 182M 11.85B 196M 1.21B 474M 5.67B 492M 482M 20.77B | 118M 138M 110M 102M 191M 12.42B 206M 1.26B 497M 5.94B 516M 505M 21.77B |
| Net Debt | -283M -329M -263M -245M -457M -29.74B -493M -3.03B -1.19B -14.23B -1.24B -1.21B -52.14B | -250M -292M -233M -217M -405M -26.33B -436M -2.68B -1.05B -12.6B -1.09B -1.07B -46.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 11.00 € | -0.90% | 9,021 |
| 13/01/26 | 11.10 € | -0.18% | 13,311 |
| 12/01/26 | 11.12 € | -1.07% | 9,255 |
| 09/01/26 | 11.24 € | -1.23% | 32,943 |
| 08/01/26 | 11.38 € | +1.43% | 14,476 |
Real-time Euronext Paris, January 14, 2026 at 04:55 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ANTIN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition